SMTL ID : 2hzn.1

Abl kinase domain in complex with NVP-AFG210

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x KIN: 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA(Non-covalent)

KIN.1: 20 residues within 4Å: Chain A: V.34, A.47, K.49, E.64, M.68, I.71, L.76, V.77, T.93, E.94, F.95, M.96, L.132, F.137, H.139, L.148, V.157, A.158, D.159, F.160 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.34, A:K.49, A:E.64, A:T.93, A:F.137, A:D.159, A:F.160 Hydrogen bonds: A:K.49, A:E.64, A:E.64, A:M.96, A:D.159

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cowan-Jacob, S.W. et al., Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia. ACTA CRYSTALLOGR.,SECT.D (2007)

Release Date

2007-01-16

Peptides

Proto-oncogene tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase ABL1

Related Entries With Identical Sequence